Augmenting vaccine efficacy against delta variant with ‘Mycobacterium- w ’ mediated modulation of NK-ADCC and TLR-MYD88 pathways
Preprint
Abstract
SUMMARY: Mycobacterium-w (Mw), was shown to boost adaptive natural killer (ANK) cells and protect against COVID-19 during the first wave of the pandemic. As a follow-up of the trial, 50 healthcare workers (HCW) who had received Mw in September 2020 and subsequently received at least one dose of ChAdOx1 nCoV-19 vaccine (Mw+ChAdOx1 group) were monitored for symptomatic COVID-19, during a major outbreak with the delta variant of SARS-CoV-2 (April-June, 2021), along with 201 HCW receiving both doses of the vaccine without Mw (ChAdOx1 group). Despite 48% having received just a single dose of the vaccine in Mw+ChAdOx1 group, only 2 had mild COVID-19, compared to 36 infections in the ChAdOx1 group (HR-0.46, p=0.009). Transcriptomic studies revealed an enhanced adaptive NK cell-dependent ADCC in the Mw+ChAdOx1 group, along with downregulation of TLR2-MYD88 pathway and concomitant attenuation of downstream inflammatory pathways. This might have resulted in robust protection during the pandemic with the delta variant.Keywords
All Related Versions
- Published version: Vaccines, 11 (2), 328.
This publication has 25 references indexed in Scilit:
- Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesThe Lancet Infectious Diseases, 2021
- Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patientsSignal Transduction and Targeted Therapy, 2021
- A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesCell Host & Microbe, 2021
- SARS-CoV-2 takes its TollNature Immunology, 2021
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokinesNature Immunology, 2021
- FcRγ Gene Editing Reprograms Conventional NK Cells to Display Key Features of Adaptive Human NK CellsiScience, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Targeting the NLRP3 Inflammasome in Severe COVID-19Frontiers in Immunology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functionsInternational Immunology, 2012